Sun Pharmaceuticals reported INR27.06B in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aspen Pharmacare APN:SJ 4.7B 344M
Bharat Petroleum BPCL:IN 49.65B 17.92B
Cipla CIPLA:IN IR 12262M 1196.9M
Dr.Reddys Laboratories DRRD:IN IR 13598M 4415M
Reliance Infra RELI:IN IR 260200M 26520M
Sun Pharmaceuticals SUNP:IN IR 27062.9M 349.1M
UPL UPLL:IN IR 20450M 1820M